Conduit Pharmaceuticals Announces Leadership Changes
1. Conduit Pharmaceuticals appoints Dr. Andrew Regan as new CEO. 2. Dr. Regan focuses on strategic growth and out-licensing deals. 3. Dr. David Tapolczay transitions to Head of Strategy & Licensing. 4. Company's innovative approach utilizes AI for drug repurposing. 5. Board expresses confidence in Regan's leadership for shareholder value.